INTERNATIONAL PATENT: ARGORNA PHARMACEUTICALS CO., LTD., GUANGZHOU RIBOBIO CO., LTD. FILES APPLICATION FOR "NUCLEIC ACID MOLECULE FOR INHIBITING OR REDUCING EXPRESSION OF TARGET GENE ANGPTL3 AND USE THEREOF"

GENEVA, Feb. 24 -- ARGORNA PHARMACEUTICALS CO., LTD. (2nd and 4th Floor, Building A, 7 Suida Street, Huangpu District,Guangzhou, Guangdong 510700), GUANGZHOU RIBOBIO CO., LTD. (7 Suida Street, Huangpu District,Guangzhou, Guangdong 510530) filed a patent application (PCT/CN2025/114467) for "NUCLEIC ACID MOLECULE FOR INHIBITING OR REDUCING EXPRESSION OF TARGET GENE ANGPTL3 AND USE THEREOF" on Aug 13, 2025. With publication no. WO/2026/037344, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Bill Biliang (7 Suida Stree...